Sarah Connor Lassey, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Labor Stage, Second | 2 | 2022 | 38 | 0.880 |
Why?
|
| Placenta Previa | 1 | 2023 | 122 | 0.790 |
Why?
|
| Cesarean Section | 5 | 2023 | 1396 | 0.780 |
Why?
|
| Obstetric Labor Complications | 3 | 2022 | 236 | 0.760 |
Why?
|
| Oxytocics | 1 | 2021 | 67 | 0.720 |
Why?
|
| Placenta Accreta | 1 | 2023 | 237 | 0.680 |
Why?
|
| Labor, Induced | 1 | 2021 | 151 | 0.670 |
Why?
|
| Home Childbirth | 1 | 2019 | 54 | 0.630 |
Why?
|
| Trial of Labor | 2 | 2022 | 81 | 0.620 |
Why?
|
| Vaginal Birth after Cesarean | 1 | 2018 | 61 | 0.560 |
Why?
|
| Oxytocin | 1 | 2021 | 402 | 0.550 |
Why?
|
| Perinatal Care | 1 | 2019 | 244 | 0.550 |
Why?
|
| Hyperemesis Gravidarum | 1 | 2016 | 23 | 0.540 |
Why?
|
| Hyponatremia | 1 | 2019 | 279 | 0.540 |
Why?
|
| Rehydration Solutions | 1 | 2016 | 43 | 0.530 |
Why?
|
| Catheterization | 1 | 2021 | 1428 | 0.500 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2016 | 109 | 0.500 |
Why?
|
| Rhabdomyolysis | 1 | 2016 | 152 | 0.490 |
Why?
|
| Parity | 1 | 2018 | 924 | 0.470 |
Why?
|
| Labor, Obstetric | 1 | 2018 | 323 | 0.470 |
Why?
|
| Aneuploidy | 1 | 2017 | 555 | 0.440 |
Why?
|
| Fluid Therapy | 1 | 2016 | 578 | 0.400 |
Why?
|
| Patient Transfer | 1 | 2019 | 793 | 0.400 |
Why?
|
| Abortion, Induced | 1 | 2017 | 462 | 0.380 |
Why?
|
| Pregnancy | 12 | 2023 | 29872 | 0.300 |
Why?
|
| Cervical Ripening | 1 | 2021 | 18 | 0.190 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2015 | 475 | 0.180 |
Why?
|
| Thrombelastography | 1 | 2023 | 187 | 0.180 |
Why?
|
| Cerclage, Cervical | 1 | 2020 | 31 | 0.170 |
Why?
|
| Pregnancy in Diabetics | 1 | 2021 | 197 | 0.160 |
Why?
|
| Catheters | 1 | 2021 | 426 | 0.150 |
Why?
|
| Uterine Rupture | 1 | 2018 | 65 | 0.140 |
Why?
|
| Uterine Neoplasms | 1 | 2015 | 1420 | 0.130 |
Why?
|
| Uterine Hemorrhage | 1 | 2018 | 240 | 0.130 |
Why?
|
| Cervix Uteri | 1 | 2020 | 570 | 0.130 |
Why?
|
| Endometrial Neoplasms | 1 | 2015 | 1365 | 0.130 |
Why?
|
| Hypokalemia | 1 | 2016 | 153 | 0.120 |
Why?
|
| Dehydration | 1 | 2016 | 216 | 0.120 |
Why?
|
| Combined Modality Therapy | 2 | 2021 | 8519 | 0.110 |
Why?
|
| Decision Support Techniques | 1 | 2023 | 2000 | 0.100 |
Why?
|
| Pregnancy Outcome | 2 | 2021 | 2920 | 0.100 |
Why?
|
| Prenatal Care | 1 | 2020 | 1141 | 0.100 |
Why?
|
| Adult | 9 | 2022 | 221083 | 0.100 |
Why?
|
| Female | 13 | 2023 | 392458 | 0.100 |
Why?
|
| Diabetes, Gestational | 1 | 2021 | 1250 | 0.090 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 12058 | 0.090 |
Why?
|
| Young Adult | 4 | 2022 | 59199 | 0.090 |
Why?
|
| Boston | 2 | 2019 | 9324 | 0.080 |
Why?
|
| Gestational Age | 1 | 2017 | 3577 | 0.080 |
Why?
|
| Laparoscopy | 1 | 2020 | 2030 | 0.070 |
Why?
|
| Time Factors | 2 | 2021 | 39953 | 0.070 |
Why?
|
| Economics, Medical | 1 | 2008 | 112 | 0.070 |
Why?
|
| Humans | 14 | 2023 | 761098 | 0.070 |
Why?
|
| Proportional Hazards Models | 1 | 2021 | 12467 | 0.070 |
Why?
|
| Double-Blind Method | 1 | 2020 | 12341 | 0.060 |
Why?
|
| Pregnancy Complications | 1 | 2019 | 2948 | 0.060 |
Why?
|
| Prostatic Neoplasms | 1 | 2008 | 11103 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2020 | 64670 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 12975 | 0.060 |
Why?
|
| Delivery, Obstetric | 2 | 2022 | 939 | 0.050 |
Why?
|
| Logistic Models | 1 | 2018 | 13254 | 0.050 |
Why?
|
| Medically Uninsured | 1 | 2008 | 835 | 0.050 |
Why?
|
| Adolescent | 2 | 2021 | 88271 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2021 | 80673 | 0.040 |
Why?
|
| SEER Program | 1 | 2015 | 1450 | 0.040 |
Why?
|
| Extraction, Obstetrical | 1 | 2020 | 27 | 0.040 |
Why?
|
| Comorbidity | 2 | 2019 | 10514 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2021 | 54419 | 0.040 |
Why?
|
| Middle Aged | 3 | 2021 | 220835 | 0.040 |
Why?
|
| Postpartum Hemorrhage | 1 | 2022 | 272 | 0.040 |
Why?
|
| Hysterectomy | 1 | 2022 | 856 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2020 | 730 | 0.030 |
Why?
|
| Risk Factors | 1 | 2023 | 74219 | 0.030 |
Why?
|
| Poverty | 1 | 2008 | 2692 | 0.030 |
Why?
|
| Emotions | 1 | 2008 | 2740 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2008 | 9648 | 0.030 |
Why?
|
| Pregnancy Trimester, First | 1 | 2020 | 908 | 0.030 |
Why?
|
| Recurrence | 1 | 2008 | 8456 | 0.030 |
Why?
|
| Placenta | 1 | 2021 | 1709 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2022 | 26187 | 0.020 |
Why?
|
| Survival Rate | 1 | 2015 | 12727 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 11118 | 0.020 |
Why?
|
| Medicare | 1 | 2015 | 6775 | 0.020 |
Why?
|
| Insulin | 1 | 2021 | 6588 | 0.020 |
Why?
|
| Quality of Life | 1 | 2008 | 13362 | 0.020 |
Why?
|
| Prognosis | 1 | 2015 | 29672 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 11732 | 0.010 |
Why?
|
| Aged | 2 | 2015 | 169266 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 39121 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 15845 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2019 | 24013 | 0.010 |
Why?
|
| United States | 1 | 2015 | 72337 | 0.010 |
Why?
|
| Male | 1 | 2008 | 360675 | 0.010 |
Why?
|